Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol

被引:48
作者
Ohno, A
Saito, Y
Hanioka, N
Jinno, H
Saeki, M
Ando, M
Ozawa, S
Sawada, J
机构
[1] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo 1588501, Japan
[2] Natl Inst Hlth Sci, Project Team Pharmacogenet, Setagaya Ku, Tokyo 1588501, Japan
[3] Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan
[4] Natl Inst Hlth Sci, Div Biochem & Immunochem, Setagaya Ku, Tokyo 1588501, Japan
关键词
D O I
10.1124/dmd.32.2.235
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carvedilol ((+/-)-1-carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy) ethyl] amino]-2-propanol) is metabolized primarily into glucuronide conjugates. In the present study, we identified the human UDP-glucuronosyltransferase (UGT) isoforms involved in the glucuronidation of carvedilol by thin-layer chromatography using microsomes from human liver or insect cells expressing recombinant UGT isoforms. We observed two forms of carvedilol glucuronides, namely G1 and G2, in hepatic microsomes. The glucuronidation of carvedilol was catalyzed by at least three recombinant UGT isoforms: UGT1A1, UGT2B4, and UGT2B7. UGT2B4 formed both G1 and G2, whereas UGT1A1 and UGT2B7 were responsible for the formation of glucuronide G2 and G1, respectively. The enzyme kinetics for carvedilol glucuronidation by UGT1A1, UGT2B4, and UGT2B7 in addition to human liver microsomes were examined by Lineweaver-Burk analysis. The values of K-m and V-max for human liver microsomes were 26.6 muM and 106 pmol/min/mg protein for G1, and 46.0 muM and 44.5 pmol/min/mg protein for G2, respectively. The K-m values for UGT1A1, UGT2B4, and UGT2B7 for G1 and G2 (22.1 - 55.1 muM) were comparable to those of the liver microsomes, whereas the V-max values were in the range of 3.33 to 7.88 pmol/min/mg protein. The K-m and V-max/K-m values for UGT2B4 and UGT2B7 for G1 were similar, whereas UGT2B4 had lower K-m and higher V-max/K-m values for G2 compared with those of UGT1A1. These results suggest that G1 formation is catalyzed by UGT2B4 and UGT2B7, whereas G2 is formed by UGT2B4 and UGT1A1. These three hepatic UGT isoforms may have important roles in carvedilol metabolism.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 27 条
[1]  
Burchell B, 2001, INTERINDIVIDUAL VARIABILITY IN HUMAN DRUG METABOLISM, P358
[2]   Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy -: A prospective, placebo-controlled trial [J].
Cice, G ;
Ferrara, L ;
D'Andrea, A ;
D'Isa, S ;
Di Benedetto, A ;
Cittadini, A ;
Russo, PE ;
Golino, P ;
Calabrò, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) :1438-1444
[3]  
Coffman BL, 1998, DRUG METAB DISPOS, V26, P73
[4]  
EGGERTSEN R, 1987, J CARDIOVASC PHA S11, V10, P97
[5]   Carvedilol [J].
Frishman, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (24) :1759-1765
[6]   IDENTIFICATION OF 2 MAJOR BILIARY METABOLITES OF CARVEDILOL IN RATS [J].
FUJIMAKI, M ;
HAKUSUI, H .
XENOBIOTICA, 1990, 20 (10) :1025-1034
[7]   Carvedilol versus verapamil in chronic stable angina: A multicentre trial [J].
HaufZachariou, U ;
Blackwood, RA ;
Gunawardena, KA ;
ODonnell, JG ;
Garnham, S ;
Pfarr, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (02) :95-100
[8]   Genetic predisposition to the metabolism of irinotecan (CPT-11) - Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes [J].
Iyer, L ;
King, CD ;
Whitington, PF ;
Green, MD ;
Roy, SK ;
Tephly, TR ;
Coffman, BL ;
Ratain, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :847-854
[9]  
Johnson JA, 2000, J PHARMACOL EXP THER, V294, P1099
[10]   UDP-glucuronosyltransferases [J].
King, CD ;
Rios, GR ;
Green, MD ;
Tephly, TR .
CURRENT DRUG METABOLISM, 2000, 1 (02) :143-161